Separate names with a comma.
IF P3 is successful then this stock could hit $80-100 per share (= Mcap $600-750M) thats not much for a Drug with $650 million potential.GL...
trading below cash of $34 million + only 7.5 million shares outstanding + attractive product in phase 3 with results expected in 1H 2018 = The...
TNXP (MC $32M) (Cash $34M) O/S 7.5 M / Phase 3 Data in 1H 2018 =More than just cheap . Found another terrible undervalued which trading below...
Small Phase 2b trial has huge chance to be successful because it was already successfull in prior studies so this stock like to be above $10 after...
Nice move today , this unknown low float rocket will run to $10 and higher with positive results in Q1 and FDA approval .GL...
Here is a very attractive and brutally undervalued canadian company called Medicenna (MDNA.TO) which is listed since March thats why its also...
nice move today and market cap is still at ridiculous $33 million .. Could hit the important $1 mark next week then more investors will likely...
